MSF WOULD LIKE TO THANK ALL THE PEOPLE WHO SHARED THEIR EXPERIENCES WITH US. WITHOUT THESE TESTIMONIES THIS REPORT WOULD NOT HAVE BEEN POSSIBLE. UNLESS OTHERWISE INDICATED ALL PATIENT NAMES HAVE BEEN CHANGED.
The UN estimates that over the last few years between 15,000 - 20,000 people living with HIV die annually in Myanmar, because of lack of access to urgent lifesaving anti-retroviral therapy (ART).
Lives in the Balance outlines the situation for people affected by HIV and TB, with a special focus on multidrug-resistant TB (MDR-TB), in Myanmar today. It calls for urgent funding and assistance to be made available by the international donor community to help Myanmar close the devastating gap between people’s need and people’s access to treatment for HIV and TB.
In 2011, following a five year absence - the Global Fund to tackle TB, AIDS and Malaria restarted in Myanmar (in Round 9). The money allocated was crucial to laying the foundations for Myanmar’s efforts to provide treatment for HIV and TB.
In expectation of further funding, the Myanmar Ministry of Health, and Non-Governmental Organisations (NGOs) have started to make credible efforts towards scaling up treatment.
Then in November 2011, just months after donors announced new HIV treatment targets, the Global Fund cancelled its next round of funding (Round 11).
The loss of the anticipated funds for HIV and TB treatment is a tremendous blow to Myanmar, the least developed country in south-east Asia . And one of the lowest recipients of Official Development Aid in the world.